Sumitomo Pharma Co., Ltd.

¥1,838As of Sun 8 Nov 2026, 12:00 UTC
TSE:4506Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR 1.18%
Div yield 0.82%
ROE 13.28%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.42
PE TTM 16.68
TSR TTM 9.11%
Mkt cap ¥824.5B
ROIC (0.35%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥1,800
(2.09%)
(63.34%)
Hold 8|7|12|11|6
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
15.53
16.11
16.77
16.31
2.29%
10.35%
20.77%
6.76%
Revenue¥B
99.92
97.09
94.64
98.04
7.22%
2.92%
(3.74%)
1.82%
Peers (US$5.235B)
Cap (US$)
PE
16.11B
10.50x
8.695B
32.35x
1.766B
9.215x
5.236B
35.06x
Capital
TTM
5Y
10Y
Leveragex
3.553
(0.131)
(0.119)
EBIT/Intx
0.186
0.452
0.338
Own earn%
3.48
(77.91)
(89.92)
Sh yield%
33.46
23.61
21.31
Owners
Insiders/Inst%
7.46
25.13
Short interest%
2.64
SBC / revenue%
3.43
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
8–12
$1 testx
—
Incr. ROIC%
10